down arrow

Syngene Intl.

Part of MojoOne Strategy
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE398R01022
  • NSEID: SYNGENE
  • BSEID: 539268
INR
703.65
13.05 (1.89%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 6.02 lacs

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationResults Declared: Syngene Intl. has declared results on 23 Apr 2025! Click here to unlock the latest financial performance
stock-summaryPrice Point
High/Low

1Day

695.20713.55

52 Week

608.00960.00
Valuation
Technical
Day's Volume

CASH

6.02 lacs (-14.21%) Volume

Shareholding (Sep 2024)

FII

20.72%

Held by 272 FIIs

DII

17.48%

Held by 38 DIIs

Promoter

54.72%

iScoreScore
Part of MojoOne Strategy
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

Poor long term growth as Net Sales has grown by an annual rate of 12.81% and Operating profit at 9.15% over the last 5 years

 
2

Flat results in Dec 24

 
3

Stock is technically in a Bearish range

4

With ROE of 10.5, it has a Very Expensive valuation with a 6.3 Price to Book Value

5

Reducing Promoter Confidence

6

Consistent Underperformance against the benchmark over the last 3 years

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 28,325 Cr (Large Cap)

stock-summary
P/E

58.00

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.17%

stock-summary
Debt Equity

-0.09

stock-summary
Return on Equity

10.49%

stock-summary
Price to Book

6.32

Revenue and Profits (1 Year):
Net Sales:
944 Cr
(Quarterly Results - Dec 2024)
Net Profit:
131 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.17%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
-20.22%
0%
-20.22%
1 Year
-3.89%
0.17%
-3.72%
2 Years
15.16%
0.27%
15.43%
3 Years
6.12%
0.45%
6.57%
4 Years
25.65%
0.42%
26.07%
5 Years
152.02%
0.67%
152.69%

Latest dividend: 1.2 per share ex-dividend date: Jun-28-2024

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
12.81%
EBIT Growth (5y)
9.15%
EBIT to Interest (avg)
13.84
Debt to EBITDA (avg)
0.98
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.68
Tax Ratio
20.19%
Dividend Payout Ratio
9.85%
Pledged Shares
0
Institutional Holding
40.17%
ROCE (avg)
17.42%
ROE (avg)
13.05%
Valuation key factors
Factor
Value
P/E Ratio
58
Industry P/E
33
Price to Book Value
6.32
EV to EBIT
47.47
EV to EBITDA
27.00
EV to Capital Employed
6.84
EV to Sales
7.74
PEG Ratio
NA
Dividend Yield
0.17%
ROCE (Latest)
13.12%
ROE (Latest)
10.49%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Sep 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 27 Schemes (13.58%)

FIIs

Held by 272 FIIs (20.72%)

Promoter with highest holding

Biocon Limited (52.46%)

Highest Public shareholder

Icici Prudential Mutual Fund - Icici Prudential Ni (4.41%)

Individual Investors Holdings

5.45%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 5.91% vs 12.83% in Sep 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2024 is 23.56% vs 40.16% in Sep 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "943.70",
          "val2": "891.00",
          "chgp": "5.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "283.60",
          "val2": "244.80",
          "chgp": "15.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "12.40",
          "val2": "13.10",
          "chgp": "-5.34%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "131.10",
          "val2": "106.10",
          "chgp": "23.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "30.05%",
          "val2": "27.47%",
          "chgp": "2.58%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Consolidated) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is -2.18% vs 21.63% in Sep 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is -13.39% vs 19.33% in Sep 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,680.70",
          "val2": "1,718.20",
          "chgp": "-2.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "414.60",
          "val2": "466.00",
          "chgp": "-11.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "24.80",
          "val2": "23.50",
          "chgp": "5.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "32.00",
          "val2": "-7.40",
          "chgp": "532.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "181.80",
          "val2": "209.90",
          "chgp": "-13.39%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "24.67%",
          "val2": "27.12%",
          "chgp": "-2.45%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 2.05% vs 16.98% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is -2.64% vs 12.54% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,624.40",
          "val2": "2,571.70",
          "chgp": "2.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "698.20",
          "val2": "697.50",
          "chgp": "0.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "37.20",
          "val2": "34.30",
          "chgp": "8.45%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "32.00",
          "val2": "-11.10",
          "chgp": "388.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "312.90",
          "val2": "321.40",
          "chgp": "-2.64%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.60%",
          "val2": "27.12%",
          "chgp": "-0.52%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is 9.26% vs 22.61% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is 9.82% vs 17.33% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,488.60",
          "val2": "3,192.90",
          "chgp": "9.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,014.40",
          "val2": "934.40",
          "chgp": "8.56%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "47.20",
          "val2": "45.20",
          "chgp": "4.42%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-11.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "510.00",
          "val2": "464.40",
          "chgp": "9.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "29.08%",
          "val2": "29.26%",
          "chgp": "-0.18%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Dec'24 - QoQstock-summary
Dec'24
Sep'24
Change(%)
Net Sales
943.70
891.00
5.91%
Operating Profit (PBDIT) excl Other Income
283.60
244.80
15.85%
Interest
12.40
13.10
-5.34%
Exceptional Items
0.00
0.00
Consolidate Net Profit
131.10
106.10
23.56%
Operating Profit Margin (Excl OI)
30.05%
27.47%
2.58%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2024 is 5.91% vs 12.83% in Sep 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2024 is 23.56% vs 40.16% in Sep 2024

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Consolidated) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
1,680.70
1,718.20
-2.18%
Operating Profit (PBDIT) excl Other Income
414.60
466.00
-11.03%
Interest
24.80
23.50
5.53%
Exceptional Items
32.00
-7.40
532.43%
Consolidate Net Profit
181.80
209.90
-13.39%
Operating Profit Margin (Excl OI)
24.67%
27.12%
-2.45%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is -2.18% vs 21.63% in Sep 2023

Direction Arrows
Consolidated Net Profit

Growth in half year ended Sep 2024 is -13.39% vs 19.33% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
2,624.40
2,571.70
2.05%
Operating Profit (PBDIT) excl Other Income
698.20
697.50
0.10%
Interest
37.20
34.30
8.45%
Exceptional Items
32.00
-11.10
388.29%
Consolidate Net Profit
312.90
321.40
-2.64%
Operating Profit Margin (Excl OI)
26.60%
27.12%
-0.52%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 2.05% vs 16.98% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in nine months ended Dec 2024 is -2.64% vs 12.54% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Consolidated) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
3,488.60
3,192.90
9.26%
Operating Profit (PBDIT) excl Other Income
1,014.40
934.40
8.56%
Interest
47.20
45.20
4.42%
Exceptional Items
-11.10
0.00
Consolidate Net Profit
510.00
464.40
9.82%
Operating Profit Margin (Excl OI)
29.08%
29.26%
-0.18%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is 9.26% vs 22.61% in Mar 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2024 is 9.82% vs 17.33% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Syngene International Ltd stock-summary
stock-summary
Syngene International Ltd
Large Cap
Pharmaceuticals & Drugs
Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors. Headquartered in India, the operations are driven by its highly qualified teams comprising ~6000 scientists and its state-of-the-art facilities, spread over 2.2 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
Company Coordinates stock-summary
Company Details
Biocon SEZ Biocon Park, Plot No 2 & 3 Bommasandra Inds Bengaluru Karnataka : 560099
stock-summary
Tel: 91-80-68915000/67758781
stock-summary
http://www.syngeneintl.com
stock-summary
investor@syngeneintl.com
Registrar Details
Karvy Computershare Pvt Ltd., Karvy Selenium, Tower-B Plot No 31 & 32, Survey No 116/22, 115/24, 115/25, Financial District, Nanakramguda, Serilingampally, Mandal Ranga Reddy Dist, Hyderabad
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."